complement decay-accelerating factor (cd55) (Optipharm PTY Ltd)
90
Structured Review
Optipharm PTY Ltd
complement decay-accelerating factor (cd55)
Complement Decay Accelerating Factor (Cd55), supplied by Optipharm PTY Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+decay-accelerating+factor+(cd55)/complement+decay+accelerating+factor++cd55+/pm40500644-36-19-0
Average 90 stars, based on 1 article reviews
Complement Decay Accelerating Factor (Cd55), supplied by Optipharm PTY Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+decay-accelerating+factor+(cd55)/complement+decay+accelerating+factor++cd55+/pm40500644-36-19-0
Average 90 stars, based on 1 article reviews
complement decay-accelerating factor (cd55) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Transgenic Assay:Article Title: Current Status of Pig-to-NHP Xenotransplantation Research in Korea. Article Snippet: Sun Ae Hwang, Sangil Min, Ki Cheul Shin, Hyun Keun Chee, Wan Seop Kim, Young Rok Choi, Hyun Suk Yang, Yu Rim Ahn, Jeong Ho Hwang, Hyunil Kim, Keon Bong Oh, and Ik Jin Yun* Department of Surgery, Konkuk University School of Medicine, Seoul, Korea; Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Hospital, Seoul, Korea; Department of Ophthalmology, Konkuk University Medical Center, Seoul, Korea; Department of Thoracic Surgery, Konkuk University Hospital, Seoul, Korea; Department of Pathology, Konkuk University School of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Bundang Hospital, Seoul, Korea; Department of Cardiology, Konkuk University School of Medicine, Seoul, Korea; Non-Human Primate Minipig Translational Toxicology research, Korea Institute of Toxicology, Jeollabuk-do, Jeonbuk, Korea; Department of Transgenic Animal Research, Optipharm, Inc., Cheongju-si, Chungcheongbuk-do, Korea; and Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup, Korea Membrane:Article Title: Current Status of Pig-to-NHP Xenotransplantation Research in Korea. Article Snippet: Sun Ae Hwang, Sangil Min, Ki Cheul Shin, Hyun Keun Chee, Wan Seop Kim, Young Rok Choi, Hyun Suk Yang, Yu Rim Ahn, Jeong Ho Hwang, Hyunil Kim, Keon Bong Oh, and Ik Jin Yun* Department of Surgery, Konkuk University School of Medicine, Seoul, Korea; Institute for Experiments of Non-clinical NHP Solid Organ Xenotransplantation, Konkuk University School of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Hospital, Seoul, Korea; Department of Ophthalmology, Konkuk University Medical Center, Seoul, Korea; Department of Thoracic Surgery, Konkuk University Hospital, Seoul, Korea; Department of Pathology, Konkuk University School of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Bundang Hospital, Seoul, Korea; Department of Cardiology, Konkuk University School of Medicine, Seoul, Korea; Non-Human Primate Minipig Translational Toxicology research, Korea Institute of Toxicology, Jeollabuk-do, Jeonbuk, Korea; Department of Transgenic Animal Research, Optipharm, Inc., Cheongju-si, Chungcheongbuk-do, Korea; and Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup, Korea |